You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lanadelumab

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hereditary Angioedema (HAE) Trial in China (Lanadelumab)

Recruiting
  • Hereditary Angioedema (HAE)
  • Lanadelumab
  • Guangzhou, Guangdong, China
  • +3 more
Jul 13, 2022

Lanadelumab in Participants With Hereditary Angioedema

Recruiting
  • Hereditary Angioedema (HAE)
  • Lanadelumab
  • Tokyo, T, Japan
    Takeda selected site
Jun 22, 2022

Healthy Volunteers Trial in Lincoln (Lanadelumab, Placebo)

Completed
Has Results
  • Healthy Volunteers
  • Lanadelumab
  • Placebo
  • Lincoln, Nebraska
    Celerion
Dec 14, 2021

Lanadelumab in Teenagers and Hereditary Angioedema (HAE)

Not yet recruiting
  • Hereditary Angioedema (HAE)
  • No Intervention
  • London, England, United Kingdom
    Barts Health NHS Trust
Jul 20, 2022

Angioedema Trial in Grenoble, Rouen

Recruiting
  • Angioedema
    • Grenoble, France
    • +1 more
    Feb 10, 2022

    Hereditary Angioedema Trial in Japan (TAK-743 300 mg)

    Completed
    • Hereditary Angioedema
    • TAK-743 300 mg
    • Toyohashi, Aichi, Japan
    • +8 more
    Jul 1, 2022

    Hemodialysis Complication, Hypotension of Hemodialysis Trial in Nashville (Lanadelumab Injection [Takhzyro], Placebo)

    Recruiting
    • Hemodialysis Complication
    • Hypotension of Hemodialysis
    • Lanadelumab Injection [Takhzyro]
    • Placebo
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Aug 4, 2022

    Hereditary Angioedema (HAE) Trial in Worldwide (Lanadelumab)

    Available
    • Hereditary Angioedema (HAE)
    • Angioedema
    • Lanadelumab 150 mg
    • Lanadelumab 300 mg
    • Scottsdale, Arizona
    • +19 more
    Sep 16, 2022

    Angioedema Trial in United States (Lanadelumab)

    Recruiting
    • Angioedema
    • Lanadelumab
    • Birmingham, Alabama
    • +7 more
    Mar 30, 2022

    Lung Injury Trial in Melbourne (Lanadelumab, Saline control)

    Recruiting
    • Lung Injury
    • Lanadelumab
    • Saline control
    • Melbourne, Victoria, Australia
      St Vincent's Hospital Melbourne
    May 4, 2022

    COVID-19 Trial in Netherlands (lanadelumab, regular care)

    Completed
    • COVID-19
    • lanadelumab
    • regular care
    • Amsterdam, Netherlands
    • +3 more
    Jul 11, 2021

    Lanadelumab in Teenagers and Hereditary Angioedema in Argentina

    Recruiting
    • Angioedemas, Hereditary
      • Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
        Ic Projects Srl
      Sep 8, 2021

      Healthy Volunteers Trial in Cypress (Lanadelumab)

      Completed
      Has Results
      • Healthy Volunteers
      • Lanadelumab
      • Cypress, California
        WCCT Global, Inc.
      May 13, 2021

      Hereditary Angioedema (HAE) Trial in Japan (Lanadelumab)

      Completed
      • Hereditary Angioedema (HAE)
      • Lanadelumab
      • Toyohashi-shi, Aichi-Ken, Japan
      • +11 more
      Sep 23, 2021

      Lanadelumab in Persons With Hereditary Angioedema in Poland

      Recruiting
      • Hereditary Angioedema (HAE)
        • Wrocław, Dolnośląskie, Poland
        • +13 more
        Jun 15, 2022

        Angioedema Trial in Worldwide (Lanadelumab, Placebo)

        Completed
        • Angioedema
        • Lanadelumab
        • Placebo
        • Birmingham, Alabama
        • +44 more
        Oct 24, 2022

        Lanadelumab in Persons With Hereditary Angioedema Type I or II

        Recruiting
        • Hereditary Angioedema (HAE)
          • Wien, Austria
          • +19 more
          Dec 13, 2021

          Teenagers and Hereditary Angioedema Type I or Type II Who Use

          Completed
          • Hereditary Angioedema (HAE)
            • Graz, Austria
            • +19 more
            Jan 12, 2023

            Healthy Volunteers Trial in Miami (SHP643)

            Completed
            Has Results
            • Healthy Volunteers
            • Miami, Florida
              Clinical Pharmacology of Miami, LLC
            Nov 12, 2020

            COVID-19 Pneumonia Trial (Lanadelumab, Placebo)

            Withdrawn
            • COVID-19 Pneumonia
            • Lanadelumab
            • Placebo
            • (no location specified)
            Oct 9, 2020

            Lanadelumab in Persons With Hereditary Angioedema Type I or II

            Active, not recruiting
            • Hereditary Angioedema (HAE)
              • Birmingham, Alabama
              • +28 more
              Dec 17, 2021

              COVID-19 Trial in Worldwide (Standard of care, Apremilast, Apremilast )

              Completed
              Has Results
              • COVID-19
              • Standard of care
              • +6 more
              • Anniston, Alabama
              • +58 more
              Jun 23, 2022

              Hereditary Angioedema Kininogen Assay

              Terminated
              • Hereditary Angioedema
                • Berlin, Germany
                • +6 more
                Mar 9, 2022

                Hereditary Angioedema Trial in United States (Donidalorsen)

                Recruiting
                • Hereditary Angioedema
                • Paradise Valley, Arizona
                • +19 more
                Jan 23, 2023

                Hereditary Angioedema (HAE) Trial in Worldwide (DX-2930 - 300mg/2wk, DX-2930 - 300mg/4wk, DX-2930 - 150mg/4wk)

                Completed
                Has Results
                • Hereditary Angioedema (HAE)
                • DX-2930 - 300mg/2wk
                • +3 more
                • Birmingham, Alabama
                • +40 more
                May 13, 2021